Skip to main content
Top
Published in: Virology Journal 1/2009

Open Access 01-12-2009 | Research

Deletions of neuraminidase and resistance to oseltamivir may be a consequence of restricted receptor specificity in recent H3N2 influenza viruses

Authors: Shelly Gulati, David F Smith, Gillian M Air

Published in: Virology Journal | Issue 1/2009

Login to get access

Abstract

Background

Influenza viruses attach to cells via sialic acid receptors. The viral neuraminidase (NA) is needed to remove sialic acids so that newly budded virions can disperse. Known mechanisms of resistance to NA inhibitors include mutations in the inhibitor binding site, or mutations in the hemagglutinin that reduce avidity for sialic acid and therefore reduce the requirement for NA activity.

Results

Influenza H3N2 isolates A/Oklahoma/323/03 (Fujian-like), A/Oklahoma/1992/05 (California-like), and A/Oklahoma/309/06 (Wisconsin-like) lost NA activity on passage in MDCK cells due to internal deletions in the NA-coding RNA segment. The viruses grow efficiently in MDCK cells despite diminished NA activity. The full length NA enzyme activity is sensitive to oseltamivir but replication of A/Oklahoma/323/03 and A/Oklahoma/309/06 in MDCK cells was resistant to this inhibitor, indicating that NA is not essential for replication. There was no change in HA activity or sequence after the NA activity was lost but the three viruses show distinct, quite restricted patterns of receptor specificity by Glycan Array analysis. Extensive predicted secondary structure in RNA segment 6 that codes for NA suggests the deletions are generated by polymerase skipping over base-paired stem regions. In general the NA deletions were not carried into subsequent passages, and we were unable to plaque-purify virus with a deleted NA RNA segment.

Conclusion

H3N2 viruses from 2003 to the present have reduced requirement for NA when passaged in MDCK cells and are resistant to NA inhibitors, possibly by a novel mechanism of narrow receptor specificity such that virus particles do not self-aggregate. These viruses delete internal regions of the NA RNA during passage and are resistant to oseltamivir. However, deletions are independently generated at each passage, suggesting that virus with a full length NA RNA segment initiates the first round of infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Palese P, Tobita K, Ueda M, Compans RW: Characterization of temperature-sensitive influenza virus mutants defective in neuraminidase. Virology 1974, 61: 397-410. 10.1016/0042-6822(74)90276-1CrossRefPubMed Palese P, Tobita K, Ueda M, Compans RW: Characterization of temperature-sensitive influenza virus mutants defective in neuraminidase. Virology 1974, 61: 397-410. 10.1016/0042-6822(74)90276-1CrossRefPubMed
2.
go back to reference Liu C, Eichelberger MC, Compans RW, Air GM: Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J Virol 1995, 69: 1099-1106.PubMedCentralPubMed Liu C, Eichelberger MC, Compans RW, Air GM: Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J Virol 1995, 69: 1099-1106.PubMedCentralPubMed
3.
go back to reference Baum LG, Paulson JC: The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity. Virology 1991, 180: 10-15. 10.1016/0042-6822(91)90003-TCrossRefPubMed Baum LG, Paulson JC: The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity. Virology 1991, 180: 10-15. 10.1016/0042-6822(91)90003-TCrossRefPubMed
4.
go back to reference Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV, Kobasa D, Kawaoka Y: Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol 2000, 74: 6015-6020. 10.1128/JVI.74.13.6015-6020.2000PubMedCentralCrossRefPubMed Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV, Kobasa D, Kawaoka Y: Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol 2000, 74: 6015-6020. 10.1128/JVI.74.13.6015-6020.2000PubMedCentralCrossRefPubMed
5.
go back to reference Wagner R, Matrosovich M, Klenk HD: Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol 2002, 12: 159-166. 10.1002/rmv.352CrossRefPubMed Wagner R, Matrosovich M, Klenk HD: Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol 2002, 12: 159-166. 10.1002/rmv.352CrossRefPubMed
6.
go back to reference Hughes MT, Matrosovich M, Rodgers ME, McGregor M, Kawaoka Y: Influenza A viruses lacking sialidase activity can undergo multiple cycles of replication in cell culture, eggs, or mice. J Virol 2000, 74: 5206-5212. 10.1128/JVI.74.11.5206-5212.2000PubMedCentralCrossRefPubMed Hughes MT, Matrosovich M, Rodgers ME, McGregor M, Kawaoka Y: Influenza A viruses lacking sialidase activity can undergo multiple cycles of replication in cell culture, eggs, or mice. J Virol 2000, 74: 5206-5212. 10.1128/JVI.74.11.5206-5212.2000PubMedCentralCrossRefPubMed
7.
go back to reference Hughes MT, McGregor M, Suzuki T, Suzuki Y, Kawaoka Y: Adaptation of influenza A viruses to cells expressing low levels of sialic acid leads to loss of neuraminidase activity. J Virol 2001, 75: 3766-3770. 10.1128/JVI.75.8.3766-3770.2001PubMedCentralCrossRefPubMed Hughes MT, McGregor M, Suzuki T, Suzuki Y, Kawaoka Y: Adaptation of influenza A viruses to cells expressing low levels of sialic acid leads to loss of neuraminidase activity. J Virol 2001, 75: 3766-3770. 10.1128/JVI.75.8.3766-3770.2001PubMedCentralCrossRefPubMed
8.
go back to reference Gulati U, Wu W, Gulati S, Kumari K, Waner JL, Air GM: Mismatched hemagglutinin and neuraminidase specificities in recent human H3N2 influenza viruses. Virology 2005, 339: 12-20. 10.1016/j.virol.2005.05.009CrossRefPubMed Gulati U, Wu W, Gulati S, Kumari K, Waner JL, Air GM: Mismatched hemagglutinin and neuraminidase specificities in recent human H3N2 influenza viruses. Virology 2005, 339: 12-20. 10.1016/j.virol.2005.05.009CrossRefPubMed
9.
go back to reference Kumari K, Gulati S, Smith DF, Gulati U, Cummings RD, Air GM: Receptor binding specificity of recent human H3N2 influenza viruses. Virol J 2007, 4: 42. 10.1186/1743-422X-4-42PubMedCentralCrossRefPubMed Kumari K, Gulati S, Smith DF, Gulati U, Cummings RD, Air GM: Receptor binding specificity of recent human H3N2 influenza viruses. Virol J 2007, 4: 42. 10.1186/1743-422X-4-42PubMedCentralCrossRefPubMed
10.
go back to reference Mathews DH, Turner DH, Zuker M: RNA secondary structure prediction. Curr Protoc Nucleic Acid Chem 2007.,Chapter 11(Unit 11): Mathews DH, Turner DH, Zuker M: RNA secondary structure prediction. Curr Protoc Nucleic Acid Chem 2007.,Chapter 11(Unit 11):
12.
go back to reference Liu C, Air GM: Selection and characterization of a neuraminidase-minus mutant of influenza virus and its rescue by cloned neuraminidase genes. Virology 1993, 194: 403-407. 10.1006/viro.1993.1276CrossRefPubMed Liu C, Air GM: Selection and characterization of a neuraminidase-minus mutant of influenza virus and its rescue by cloned neuraminidase genes. Virology 1993, 194: 403-407. 10.1006/viro.1993.1276CrossRefPubMed
13.
go back to reference Fujii K, Fujii Y, Noda T, Muramoto Y, Watanabe T, Takada A, Goto H, Horimoto T, Kawaoka Y: Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions. J Virol 2005, 79: 3766-3774. 10.1128/JVI.79.6.3766-3774.2005PubMedCentralCrossRefPubMed Fujii K, Fujii Y, Noda T, Muramoto Y, Watanabe T, Takada A, Goto H, Horimoto T, Kawaoka Y: Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions. J Virol 2005, 79: 3766-3774. 10.1128/JVI.79.6.3766-3774.2005PubMedCentralCrossRefPubMed
14.
go back to reference Fujii Y, Goto H, Watanabe T, Yoshida T, Kawaoka Y: Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci USA 2003, 100: 2002-2007. 10.1073/pnas.0437772100PubMedCentralCrossRefPubMed Fujii Y, Goto H, Watanabe T, Yoshida T, Kawaoka Y: Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci USA 2003, 100: 2002-2007. 10.1073/pnas.0437772100PubMedCentralCrossRefPubMed
15.
go back to reference Odagiri T, Tashiro M: Segment-specific noncoding sequences of the influenza virus genome RNA are involved in the specific competition between defective interfering RNA and its progenitor RNA segment at the virion assembly step. J Virol 1997, 71: 2138-2145.PubMedCentralPubMed Odagiri T, Tashiro M: Segment-specific noncoding sequences of the influenza virus genome RNA are involved in the specific competition between defective interfering RNA and its progenitor RNA segment at the virion assembly step. J Virol 1997, 71: 2138-2145.PubMedCentralPubMed
16.
go back to reference Chambers TM, Webster RG: Defective interfering virus associated with A/Chicken/Pennsylvania/83 influenza virus. J Virol 1987, 61: 1517-1523.PubMedCentralPubMed Chambers TM, Webster RG: Defective interfering virus associated with A/Chicken/Pennsylvania/83 influenza virus. J Virol 1987, 61: 1517-1523.PubMedCentralPubMed
17.
go back to reference Jennings PA, Finch JT, Winter G, Robertson JS: Does the higher order structure of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA? Cell 1983, 34: 619-627. 10.1016/0092-8674(83)90394-XCrossRefPubMed Jennings PA, Finch JT, Winter G, Robertson JS: Does the higher order structure of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA? Cell 1983, 34: 619-627. 10.1016/0092-8674(83)90394-XCrossRefPubMed
18.
go back to reference Kantorovich-Prokudina EN, Semyonova NP, Berezina ON, Zhdanov VM: Gradual changes of influenza virions during passage of undiluted material. J Gen Virol 1980, 50: 23-31. 10.1099/0022-1317-50-1-23CrossRefPubMed Kantorovich-Prokudina EN, Semyonova NP, Berezina ON, Zhdanov VM: Gradual changes of influenza virions during passage of undiluted material. J Gen Virol 1980, 50: 23-31. 10.1099/0022-1317-50-1-23CrossRefPubMed
19.
go back to reference Davis AR, Hiti AL, Nayak DP: Influenza defective interfering viral RNA is formed by internal deletion of genomic RNA. Proc Natl Acad Sci USA 1980, 77: 215-219. 10.1073/pnas.77.1.215PubMedCentralCrossRefPubMed Davis AR, Hiti AL, Nayak DP: Influenza defective interfering viral RNA is formed by internal deletion of genomic RNA. Proc Natl Acad Sci USA 1980, 77: 215-219. 10.1073/pnas.77.1.215PubMedCentralCrossRefPubMed
20.
go back to reference Kaverin NV, Gambaryan AS, Bovin NV, Rudneva IA, Shilov AA, Khodova OM, Varich NL, Sinitsin BV, Makarova NV, Kropotkina EA: Postreassortment changes in influenza A virus hemagglutinin restoring HA-NA functional match. Virology 1998, 244: 315-321. 10.1006/viro.1998.9119CrossRefPubMed Kaverin NV, Gambaryan AS, Bovin NV, Rudneva IA, Shilov AA, Khodova OM, Varich NL, Sinitsin BV, Makarova NV, Kropotkina EA: Postreassortment changes in influenza A virus hemagglutinin restoring HA-NA functional match. Virology 1998, 244: 315-321. 10.1006/viro.1998.9119CrossRefPubMed
21.
go back to reference Lu B, Zhou H, Ye D, Kemble G, Jin H: Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics. J Virol 2005, 79: 6763-6771. 10.1128/JVI.79.11.6763-6771.2005PubMedCentralCrossRefPubMed Lu B, Zhou H, Ye D, Kemble G, Jin H: Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics. J Virol 2005, 79: 6763-6771. 10.1128/JVI.79.11.6763-6771.2005PubMedCentralCrossRefPubMed
22.
go back to reference Air GM, Laver WG: Red cells bound to influenza virus N9 neuraminidase are not released by the N9 neuraminidase activity. Virology 1995, 211: 278-284. 10.1006/viro.1995.1401CrossRefPubMed Air GM, Laver WG: Red cells bound to influenza virus N9 neuraminidase are not released by the N9 neuraminidase activity. Virology 1995, 211: 278-284. 10.1006/viro.1995.1401CrossRefPubMed
23.
go back to reference Yang P, Bansal A, Liu C, Air GM: Hemagglutinin specificity and neuraminidase coding capacity of neuraminidase-deficient influenza viruses. Virology 1997, 229: 155-165. 10.1006/viro.1996.8421CrossRefPubMed Yang P, Bansal A, Liu C, Air GM: Hemagglutinin specificity and neuraminidase coding capacity of neuraminidase-deficient influenza viruses. Virology 1997, 229: 155-165. 10.1006/viro.1996.8421CrossRefPubMed
24.
go back to reference Bantia S, Ghate AA, Ananth SL, Babu YS, Air GM, Walsh GM: Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140. Antimicrob Agents Chemother 1998,42(4):801-807.PubMedCentralPubMed Bantia S, Ghate AA, Ananth SL, Babu YS, Air GM, Walsh GM: Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140. Antimicrob Agents Chemother 1998,42(4):801-807.PubMedCentralPubMed
25.
go back to reference Gubareva LV: Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Virus Res 2004, 103: 199-203. 10.1016/j.virusres.2004.02.034CrossRefPubMed Gubareva LV: Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Virus Res 2004, 103: 199-203. 10.1016/j.virusres.2004.02.034CrossRefPubMed
26.
go back to reference McKimm-Breschkin JL: Resistance of influenza viruses to neuraminidase inhibitors – a review. Antiviral Res 2000, 47: 1-17. 10.1016/S0166-3542(00)00103-0CrossRefPubMed McKimm-Breschkin JL: Resistance of influenza viruses to neuraminidase inhibitors – a review. Antiviral Res 2000, 47: 1-17. 10.1016/S0166-3542(00)00103-0CrossRefPubMed
27.
go back to reference Staschke KA, Colacino JM, Baxter AJ, Air GM, Bansal A, Hornback WJ, Munroe JE, Laver WG: Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en. Virology 1995, 214: 642-646. 10.1006/viro.1995.0078CrossRefPubMed Staschke KA, Colacino JM, Baxter AJ, Air GM, Bansal A, Hornback WJ, Munroe JE, Laver WG: Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en. Virology 1995, 214: 642-646. 10.1006/viro.1995.0078CrossRefPubMed
28.
go back to reference Ferraris O, Kessler N, Valette M, Lina B: Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005. Vaccine 2006, 24: 6656-6659. 10.1016/j.vaccine.2006.05.050CrossRefPubMed Ferraris O, Kessler N, Valette M, Lina B: Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005. Vaccine 2006, 24: 6656-6659. 10.1016/j.vaccine.2006.05.050CrossRefPubMed
29.
go back to reference Cairns HJF, Fazekas de St Groth S, Edney M: Quantitative aspects of influenza virus multiplication. J Immunol 1952, 69: 155-181.PubMed Cairns HJF, Fazekas de St Groth S, Edney M: Quantitative aspects of influenza virus multiplication. J Immunol 1952, 69: 155-181.PubMed
30.
go back to reference Fields S, Winter G: Nucleotide sequences of influenza virus segments 1 and 3 reveal mosaic structure of a small viral RNA segment. Cell 1982, 28: 303-313. 10.1016/0092-8674(82)90348-8CrossRefPubMed Fields S, Winter G: Nucleotide sequences of influenza virus segments 1 and 3 reveal mosaic structure of a small viral RNA segment. Cell 1982, 28: 303-313. 10.1016/0092-8674(82)90348-8CrossRefPubMed
31.
go back to reference Potier M, Mameli L, Bélisle M, Dallaire L, Melançon SB: Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl)-α-D-N-acetylneuraminate substrate. Anal Biochem 1979, 94: 287-296. 10.1016/0003-2697(79)90362-2CrossRefPubMed Potier M, Mameli L, Bélisle M, Dallaire L, Melançon SB: Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl)-α-D-N-acetylneuraminate substrate. Anal Biochem 1979, 94: 287-296. 10.1016/0003-2697(79)90362-2CrossRefPubMed
Metadata
Title
Deletions of neuraminidase and resistance to oseltamivir may be a consequence of restricted receptor specificity in recent H3N2 influenza viruses
Authors
Shelly Gulati
David F Smith
Gillian M Air
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2009
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-6-22

Other articles of this Issue 1/2009

Virology Journal 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.